$ALAB

Mazzara Philip sold $232K of ALAB

Mazzara Philip (General Counsel and Secretary) sold 796 shares of Astera Labs, Inc. (ALAB) at $291.03 ($0.23M total) on 2026-05-21.

Original reporting
SEC EDGAR · Mazzara Philip
Published May 26, 2026, 8:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ALAB
Neutral
medium confidence
Mentioned
$ALAB
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALABNeutralLow
01

Why it matters

The main tradable element is sentiment around insider behavior (selling) rather than any operational or financial update.

02

Market read

Traders may briefly reassess ALAB sentiment due to insider selling, but there is no fundamental company catalyst in the filing details provided.

03

What to watch

Check for clustering of subsequent Form 4s, changes in total insider ownership, and whether the sale coincides with option exercises or vesting-related liquidity needs.

Relevance 6/10Timing: Immediate (new Form 4 filed 2026-05-26; tradeable as a sentiment/positioning signal).

Background

The article is a SEC Form 4 disclosure of an officer’s direct open-market sale of Astera Labs shares.

Company-level read

Ticker impact

$ALABNeutralMedium confidence
Context

Astera Labs (ALAB) disclosed an open-market sale by its General Counsel/Secretary (S) of 796 shares for ~$231.7K on 2026-05-21.

Expected impact

Likely limited near-term impact; any reaction should fade unless follow-on filings show sustained selling.

Evidence & confidence

This is a Form 4 insider transaction (not earnings/M&A/regulatory). The filing notes no pre-arranged 10b5-1 plan, which can increase short-term interpretive risk, but the disclosed size is relatively small and does not indicate a company event.

Market effects

Minimal; single-company insider sale typically does not reset sector fundamentals.

None indicated; US-listed issuer filing only.

None indicated; no cross-border deal/regulatory event mentioned.

Counterpoint

Insider sales can be routine for diversification/taxes; absence of a stated 10b5-1 plan does not necessarily imply negative outlook.

Key entities

  • Astera Labs, Inc.

    Subject of the Form 4 insider transaction; General Counsel/Secretary sold 796 shares for ~$231.7K.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRDOMed

3 Under-the-Radar AI Stocks Wall Street Is Missing

Credo Technology (CRDO) reported Q4 2026 revenue of $437M, up 157% YoY, with guidance for 80% YoY growth in 2027. Astera Labs (ALAB) saw Q2 2026 revenue of $392.4M, up 104% YoY, with Scorpio X series ramping ahead of schedule. Camtek (CAMT) reported Q2 2026 revenue of $133.24M, up 8% YoY, with a strong order book extending into 2027.

$ALABMed

Astera Labs vs. monday.com: Comparing Revenue Trends Between These High-Growth Tech Companies

Astera Labs (ALAB) and monday.com (MNDY) both reported quarterly revenue growth. Astera Labs, which provides semiconductor-based connectivity solutions, saw revenue rise rapidly, surpassing monday.com in Q2 2026. It reported a 39% net income margin and forecasts Q3 revenue of $540M-$560M. monday.com, offering a cloud-native digital work operating system, reported a 6% operating margin and expects Q3 revenue of $368M-$370M, up 16-17% YoY. Both companies have shown consistent growth, with Astera L